explore -WSS

explore

author：Wikipedia 2025-09-30 11:57:47 - browse：9

When is a billion-dollar deal a bad omen? Has Wall Street gone overboard on Ozempic? And how do you edit a chicken?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss Bristol Myers Squibb’s multibillion-dollar acquisition of Mirati Therapeutics and what it means for a biotech sector still in a slump. We also explain the latest news in the life sciences, including Wall Street’s freakout over GLP-1, CRISPR’ing animals, and the latest in the NASH saga.

For more on what we cover, here’s the news on Mirati; here’s more on biotech venture capital; here’s the latest on Alnylam Pharmaceuticals; here’s more on NASH; here’s the story on xenotransplantation; here’s more on genome-edited chickens; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： NYU Langone launches private ChatGPT for its health care data

entertainment

WSS

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

CDC advisory panel says seniors 'may' get RSV vaccine

2024 GOP presidential candidates spar over abortion in debate

Study finds new variant for Parkinson’s in African populations

CDC advisory panel says seniors 'may' get RSV vaccine

leisure time

explore

focus

Medicare details structure of new drug price negotiation program

Vertex Pharmaceuticals may move headquarters in Boston

At least 13 dead in Texas as scorching temps continue

CDC advisory panel says seniors 'may' get RSV vaccine

Medical records are filled with copy

Psilocybin's anti

Trump demands the U.S. pay no more for drugs than other countries … again

How Long Island became the ‘eugenics capital of the world’

Psychedelics group wrestles with new pharma identity

How a symptom of dementia informs our understanding of creativity

hotspot

Roche subsidiary Foundation Medicine opens new headquarters

As pharma fights Medicare drug negotiation, hospitals, docs silent

AstraZeneca bets AAV gene therapy will still deliver the goods

AstraZeneca bets AAV gene therapy will still deliver the goods

Medicare explains how it will choose drugs for negotiation

What AAP's gender

knowledge

entertainment

focus

focus